PHARMACEUTICAL RETAILERS

Sep 28, 2026

PetMed Express, Inc. has filed to register an additional 1.8 million shares of common stock under an amendment to its 2024 Omnibus Incentive Plan. The company, classified as a non-accelerated filer and smaller reporting company, submitted the Form S-8 registration statement on September 28, 2026. This action expands the number of shares available under the incentive plan, which was updated on August 11, 2026.

Sep 28, 2026

High Tide Inc. (TSX:HITI), a cannabis retail company, is in focus today due to new recognition in a Canadian growth-company ranking. While broader market movements like surging crude and inflation concerns impact the overall TSX, the article emphasizes that company-specific updates and commercial activity are more relevant to HITI's story. The TSX Venture Composite Index provides context, but the firm's core operations and specific achievements are the primary drivers of its current market attention.

Sep 27, 2026

Wall Street Zen downgraded High Tide (NASDAQ:HITI) from "Buy" to "Hold," leading to mixed analyst opinions. Despite this, MarketBeat maintains a "Moderate Buy" consensus with an average price target of $5.62. High Tide recently surpassed Q3 earnings and revenue estimates, reporting $0.09 EPS and $141.74 million in revenue, though it recorded a negative net margin of 4.73%.

Sep 25, 2026

High Tide (NASDAQ:HITI) is facing market volatility due to policy expectations and capital access within the cannabis sector. The key question for investors is whether its cannabis retail and e-commerce model can deliver consistent execution. While broader market context like the Nasdaq Composite is relevant, the company's specific disclosures and operational performance will be crucial in determining its future success.